Vor Biopharma Inc.(VOR)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

VOR Vor Biopharma Inc.

交易中 04-27 12:51:51 EDT

13.89

+0.08

+0.58%

最高14.59	最低13.82	成交量32.86万
今开13.82	昨收13.81	日振幅5.58%
总市值7.53亿	流通市值6.07亿	总股本5,419万
成交额467.51万	换手率0.75%	流通股本4,371万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"VOR","market":"US","secType":"STK","nameCN":"Vor Biopharma Inc.","latestPrice":13.89,"timestamp":1777308706763,"preClose":13.81,"halted":0,"volume":328639,"delay":0,"changeRate":0.005792903692976109,"floatShares":43710400,"shares":54185600,"eps":-70.501465,"marketStatus":"交易中","change":0.08,"latestTime":"04-27 12:51:51 EDT","open":13.82,"high":14.59,"low":13.82,"amount":4675058.695446,"amplitude":0.055757,"askPrice":13.86,"askSize":31,"bidPrice":13.84,"bidSize":400,"shortable":3,"etf":0,"ttmEps":-70.501465,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1777320000000},"marketStatusCode":2,"adr":0,"listingDate":1612501200000,"exchange":"NASDAQ","adjPreClose":13.81,"preHourTrading":{"tag":"盘前","latestPrice":13.9,"preClose":13.81,"latestTime":"09:29 EDT","volume":8131,"amount":113421.83961000001,"timestamp":1777296599999,"change":0.09,"changeRate":0.006517,"amplitude":0.03693},"postHourTrading":{"tag":"盘后","latestPrice":14.2,"preClose":13.81,"latestTime":"19:53 EDT","volume":7327,"amount":101678.45,"timestamp":1777074810988,"change":0.39,"changeRate":0.02824,"amplitude":0.02824},"volumeRatio":0.59537,"impliedVol":1.3167,"impliedVolPercentile":0.3267},"requestUrl":"/m/hq/s/VOR/wiki","defaultTab":"wiki","newsList":[{"id":"2626192923","title":"荣昌生物：公司2025年第四季度利润增长主要系公司在第四季度确认了与Vor Biopharma Inc.就RC18达成的授权许可首付款收入","url":"https://stock-news.laohu8.com/highlight/detail?id=2626192923","media":"证券日报","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626192923?lang=zh_cn&edition=full","pubTime":"2026-04-10 19:28","pubTimestamp":1775820480,"startTime":"0","endTime":"0","summary":"证券日报网讯4月10日，荣昌生物在互动平台回答投资者提问时表示，公司2025年第四季度利润增长主要系公司在第四季度确认了与VorBiopharmaInc.就RC18达成的授权许可首付款收入，该笔收入在第四季度完成相关合同义务履行并确认。同时，核心产品泰它西普、维迪西妥单抗的销售收入亦保持良好增长态势。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604103701423440.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1064131003.USD","LU2328871848.SGD","LU2488822045.USD","VOR","09995","BK0239","688331","BK1574","BK1583","LU1064130708.USD","LU1969619763.USD","LU2148510915.USD","BK1161","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134111664","title":"Vor Biopharma启动泰立西普治疗原发性干燥综合征全球三期注册试验，首位患者完成给药","url":"https://stock-news.laohu8.com/highlight/detail?id=1134111664","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1134111664?lang=zh_cn&edition=full","pubTime":"2026-03-30 20:06","pubTimestamp":1774872416,"startTime":"0","endTime":"0","summary":"Vor Biopharma Inc.（简称：Vor Bio）宣布，其针对原发性干燥综合征（pSS）开发的创新药物泰立西普（Telitacicept），已在全球三期注册临床试验“Upstream Sjd”中完成对首位患者的给药。这一重要进展标志着该药物正式进入关键临床验证阶段。\n该试验旨在评估泰立西普在治疗原发性干燥综合征患者中的有效性与安全性。作为一项全球性研究，其数据结果将用于支持未来向监管机构提交的上市申请。\n此次进展为原发性干燥综合征的治疗领域带来了新的希望，也体现了Vor Bio在自身免疫疾病药物研发方面的持续投入与专业实力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VOR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121110994","title":"Vor Biopharma Inc. - 股东拟转售1390万股普通股之招股说明书 - 美国证监会文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1121110994","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1121110994?lang=zh_cn&edition=full","pubTime":"2026-01-30 05:17","pubTimestamp":1769721459,"startTime":"0","endTime":"0","summary":"根据美国证券交易委员会（SEC）最新披露的文件显示，生物制药公司Vor Biopharma Inc.已提交招股说明书，其现有股东计划公开转售1390万股公司普通股。\n此次股份转售涉及多位售股股东，相关文件已按监管要求完成备案程序。招股说明书中详细列明了股份转售的具体条款、股东信息及潜在风险因素等内容。\n该文件的公布为市场提供了公司股权结构变动的重要参考依据，投资者可据此评估流通股数量增加对股价的潜在影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VOR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175976028","title":"Vor Biopharma Inc.任命Ra Capital的Andrew Levin医学博士及Forbion的Wouter Joustra为董事会成员","url":"https://stock-news.laohu8.com/highlight/detail?id=1175976028","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1175976028?lang=zh_cn&edition=full","pubTime":"2025-12-24 05:02","pubTimestamp":1766523775,"startTime":"0","endTime":"0","summary":"Vor Biopharma Inc.任命Ra Capital的Andrew Levin医学博士及Forbion的Wouter Joustra为董事会成员","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VOR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172598054","title":"Vor Biopharma Inc. - 在对成人IgA肾病评估Telitacicept的三期临床研究A阶段中达到主要终点","url":"https://stock-news.laohu8.com/highlight/detail?id=1172598054","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1172598054?lang=zh_cn&edition=full","pubTime":"2025-11-09 00:48","pubTimestamp":1762620491,"startTime":"0","endTime":"0","summary":"Vor Biopharma Inc. - 在对成人IgA肾病评估Telitacicept的三期临床研究A阶段中达到主要终点","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VOR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161096783","title":"Telitacicept在48周中国III期开放标签扩展试验中显示持续疗效及良好安全性","url":"https://stock-news.laohu8.com/highlight/detail?id=1161096783","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1161096783?lang=zh_cn&edition=full","pubTime":"2025-10-29 23:02","pubTimestamp":1761750130,"startTime":"0","endTime":"0","summary":"Telitacicept在48周中国III期开放标签扩展试验中显示持续疗效及良好安全性","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VOR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108854682","title":"修正-Vor Biopharma Inc. : H.c. Wainwright 将目标价提高至 $55（不是 $52），基于 1拆20 股票回购（澄清目标价已调整）","url":"https://stock-news.laohu8.com/highlight/detail?id=1108854682","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1108854682?lang=zh_cn&edition=full","pubTime":"2025-10-29 20:54","pubTimestamp":1761742459,"startTime":"0","endTime":"0","summary":"修正-Vor Biopharma Inc. : H.c. Wainwright 将目标价提高至 $55（不是 $52），基于 1拆20 股票回购（澄清目标价已调整）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VOR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518806279","title":"Vor Biopharma Inc.盘中异动 急速下挫5.00%报0.950美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518806279","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518806279?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:22","pubTimestamp":1741616539,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时22分，Vor Biopharma Inc.股票出现波动，股价大幅下挫5.00%。截至发稿，该股报0.950美元/股，成交量1.0984万股，换手率0.01%，振幅7.99%。Vor Biopharma Inc.股票所在的生物技术行业中，整体涨幅为0.47%。其相关个股中，Checkpoint Therapeutics, Inc.、Mineralys Therapeutics, Inc.、Aeon Biopharma, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃，换手率分别为3400.89%、719.71%、414.19%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Scisparc Ltd.、Biodexa Pharmaceuticals Plc，振幅分别为41.36%、40.24%、39.34%。Vor Biopharma Inc.公司简介：Vor Biopharma Inc 是一家处于临床阶段的细胞治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310222219abf30f41&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310222219abf30f41&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VOR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516608852","title":"Vor Biopharma Inc.盘中异动 早盘股价大跌5.46%报0.900美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516608852","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516608852?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:35","pubTimestamp":1741098917,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时35分，Vor Biopharma Inc.股票出现波动，股价快速下挫5.46%。截至发稿，该股报0.900美元/股，成交量5.9896万股，换手率0.05%，振幅6.10%。Vor Biopharma Inc.股票所在的生物技术行业中，整体涨幅为0.11%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Protagenic Therapeutics, Inc.、Exicure, Inc.涨幅较大，Aeon Biopharma, Inc.、Windtree Therapeutics, Inc.、Protagenic Therapeutics, Inc.较为活跃，换手率分别为1076.47%、1070.68%、423.99%，振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、Adma Biologics Inc、Ibio, Inc.，振幅分别为23.30%、12.57%、12.01%。Vor Biopharma Inc.公司简介：Vor Biopharma Inc 是一家处于临床阶段的细胞治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223517963945c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223517963945c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VOR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514781403","title":"Vor Biopharma Inc.盘中异动 早盘股价大跌14.32%报0.951美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514781403","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514781403?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:31","pubTimestamp":1740753064,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时31分，Vor Biopharma Inc.股票出现异动，股价急速下跌14.32%。截至发稿，该股报0.951美元/股，成交量3.5882万股，换手率0.03%，振幅5.32%。Vor Biopharma Inc.股票所在的生物技术行业中，整体涨幅为0.02%。其相关个股中，Tc Biopharm  Plc C/Wts 10/02/2028 、Anaptysbio, Inc.、Enveric Biosciences, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Virpax Pharmaceuticals, Inc.、Enveric Biosciences, Inc.较为活跃，换手率分别为480.24%、239.11%、55.69%，振幅较大的相关个股有Trevi Therapeutics, Inc.、Enanta Pharmaceuticals, Inc.、Aardvark Therapeutics, Inc.，振幅分别为7.11%、6.58%、6.22%。Vor Biopharma Inc.公司简介：Vor Biopharma Inc 是一家处于临床阶段的细胞治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223104a25800bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223104a25800bf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","VOR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514626948","title":"Vor Biopharma Inc.盘中异动 急速下挫5.55%报1.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514626948","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514626948?lang=zh_cn&edition=full","pubTime":"2025-02-27 04:21","pubTimestamp":1740601275,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日04时21分，Vor Biopharma Inc.股票出现波动，股价快速下挫5.55%。截至发稿，该股报1.19美元/股，成交量17.4441万股，换手率0.14%，振幅5.56%。Vor Biopharma Inc.股票所在的生物技术行业中，整体跌幅为0.69%。其相关个股中，Enveric Biosciences, Inc.、Renovaro Inc.、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Enveric Biosciences, Inc.、Aeon Biopharma, Inc.、Organovo Holdings, Inc.较为活跃，换手率分别为6817.48%、325.68%、264.02%，振幅较大的相关个股有Enveric Biosciences, Inc.、Renovaro Inc.、Immatics N V C/Wts 01/07/2025 ，振幅分别为194.07%、81.11%、70.39%。Vor Biopharma Inc.公司简介：Vor Biopharma Inc 是一家处于临床阶段的细胞治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227042115a255441a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227042115a255441a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","VOR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514801932","title":"Vor Biopharma Inc.盘中异动 早盘大幅下挫5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514801932","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514801932?lang=zh_cn&edition=full","pubTime":"2025-02-26 00:00","pubTimestamp":1740499251,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日00时00分，Vor Biopharma Inc.股票出现异动，股价大幅下跌5.30%。截至发稿，该股报1.25美元/股，成交量11.8788万股，换手率0.10%，振幅6.06%。Vor Biopharma Inc.股票所在的生物技术行业中，整体涨幅为0.79%。其相关个股中，Organovo Holdings, Inc.、Silexion Therapeutics Corp、Abpro Holdings Inc C/Wts 12/11/2029 涨幅较大，Organovo Holdings, Inc.、Gt Biopharma, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为1208.43%、1099.66%、767.55%，振幅较大的相关个股有Organovo Holdings, Inc.、Silexion Therapeutics Corp、Adial Pharmaceuticals, Inc，振幅分别为224.93%、87.83%、64.05%。Vor Biopharma Inc.公司简介：Vor Biopharma Inc 是一家处于临床阶段的细胞治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226000051abdc93c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226000051abdc93c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VOR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512616571","title":"Vor Biopharma Inc.盘中异动 股价大涨5.47%报1.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512616571","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512616571?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:50","pubTimestamp":1739890200,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时50分，Vor Biopharma Inc.股票出现波动，股价快速上涨5.47%。截至发稿，该股报1.45美元/股，成交量8.5405万股，换手率0.07%，振幅3.65%。Vor Biopharma Inc.股票所在的生物技术行业中，整体涨幅为0.97%。Vor Biopharma Inc.公司简介：Vor Biopharma Inc 是一家处于临床阶段的细胞治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218225000988a00d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218225000988a00d0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","VOR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511521510","title":"Vor Biopharma Inc.盘中异动 早盘大幅下跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511521510","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511521510?lang=zh_cn&edition=full","pubTime":"2025-02-13 23:00","pubTimestamp":1739458821,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日23时00分，Vor Biopharma Inc.股票出现波动，股价大幅下跌5.07%。截至发稿，该股报1.31美元/股，成交量5.8533万股，换手率0.05%，振幅7.97%。Vor Biopharma Inc.股票所在的生物技术行业中，整体涨幅为0.17%。其相关个股中，Edesa Biotech, Inc.、Enanta Pharmaceuticals, Inc.、Nutriband Inc C/Wts 涨幅较大，Edesa Biotech, Inc.、Tc Biopharm  Plc、Genprex, Inc.较为活跃，换手率分别为1588.24%、1101.18%、121.07%，振幅较大的相关个股有天演药业、Immatics N V C/Wts 01/07/2025 、Edesa Biotech, Inc.，振幅分别为103.88%、92.30%、73.65%。Vor Biopharma Inc.公司简介：Vor Biopharma Inc 是一家处于临床阶段的细胞治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021323002198843210&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021323002198843210&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VOR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510339562","title":"Vor Biopharma Inc.盘中异动 股价大跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510339562","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510339562?lang=zh_cn&edition=full","pubTime":"2025-02-11 23:40","pubTimestamp":1739288457,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日23时40分，Vor Biopharma Inc.股票出现波动，股价急速下跌5.07%。截至发稿，该股报1.31美元/股，成交量12.1656万股，换手率0.10%，振幅5.43%。Vor Biopharma Inc.股票所在的生物技术行业中，整体跌幅为1.74%。其相关个股中，Ocean Biomedical, Inc.、In8Bio, Inc.、Lipella Pharmaceuticals Inc.涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃，换手率分别为2708.70%、1072.36%、373.67%，振幅较大的相关个股有Dominari Holdings Inc.、Ocean Biomedical, Inc.、In8Bio, Inc.，振幅分别为58.60%、57.43%、37.99%。Vor Biopharma Inc.公司简介：Vor Biopharma Inc 是一家处于临床阶段的细胞治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211234057abcb1598&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211234057abcb1598&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","VOR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510866460","title":"Vor Biopharma Inc.盘中异动 早盘快速下挫6.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510866460","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510866460?lang=zh_cn&edition=full","pubTime":"2025-02-10 22:35","pubTimestamp":1739198136,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日22时35分，Vor Biopharma Inc.股票出现波动，股价大幅下挫6.38%。Vor Biopharma Inc.股票所在的生物技术行业中，整体涨幅为0.23%。其相关个股中，60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Ocean Biomedical, Inc.、Nls Pharmaceutics Ltd.涨幅较大，Nls Pharmaceutics Ltd.、Ocean Biomedical, Inc.、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为966.65%、628.56%、259.86%，振幅较大的相关个股有Invivyd, Inc.、Ocean Biomedical, Inc.、Nls Pharmaceutics Ltd.，振幅分别为29.90%、26.71%、22.45%。Vor Biopharma Inc.公司简介：Vor Biopharma Inc 是一家处于临床阶段的细胞治疗公司。公司的产品包括 VOR33。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223536abc9a65f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223536abc9a65f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","VOR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509278487","title":"Vor Biopharma Inc.盘中异动 股价大跌6.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509278487","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509278487?lang=zh_cn&edition=full","pubTime":"2025-02-08 02:23","pubTimestamp":1738952587,"startTime":"0","endTime":"0","summary":"北京时间2025年02月08日02时23分，Vor Biopharma Inc.股票出现波动，股价大幅下跌6.00%。截至发稿，该股报1.41美元/股，成交量29.2936万股，换手率0.23%，振幅8.00%。Vor Biopharma Inc.股票所在的生物技术行业中，整体跌幅为0.55%。Vor Biopharma Inc.公司简介：Vor Biopharma Inc 是一家处于临床阶段的细胞治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208022307a23d5473&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208022307a23d5473&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","VOR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509231764","title":"Vor Biopharma Inc.盘中异动 临近午盘急速拉升5.40%报1.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509231764","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509231764?lang=zh_cn&edition=full","pubTime":"2025-02-06 00:39","pubTimestamp":1738773563,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日00时39分，Vor Biopharma Inc.股票出现异动，股价急速拉升5.40%。截至发稿，该股报1.47美元/股，成交量18.259万股，换手率0.15%，振幅7.86%。Vor Biopharma Inc.股票所在的生物技术行业中，整体涨幅为1.33%。其相关个股中，Oragenics Inc.、Transcode Therapeutics, Inc.、Pasithea Therapeutics Corp.涨幅较大，Pasithea Therapeutics Corp.、Transcode Therapeutics, Inc.、Oragenics Inc.较为活跃，换手率分别为4334.48%、1964.10%、1335.90%，振幅较大的相关个股有Transcode Therapeutics, Inc.、Oragenics Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028，振幅分别为99.51%、59.80%、54.05%。Vor Biopharma Inc.公司简介：Vor Biopharma Inc 是一家处于临床阶段的细胞治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206003923987b917f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206003923987b917f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VOR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508463303","title":"Vor Biopharma Inc.盘中异动 早盘大幅拉升5.37%报1.41美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508463303","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508463303?lang=zh_cn&edition=full","pubTime":"2025-02-04 23:15","pubTimestamp":1738682152,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日23时15分，Vor Biopharma Inc.股票出现波动，股价快速上涨5.37%。截至发稿，该股报1.41美元/股，成交量7.5497万股，换手率0.06%，振幅5.60%。Vor Biopharma Inc.股票所在的生物技术行业中，整体涨幅为1.22%。其相关个股中，Azitra Inc、Evaxion Biotech As、Nutriband Inc C/Wts 涨幅较大，Azitra Inc、Evaxion Biotech As、Enveric Biosciences, Inc.较为活跃，换手率分别为1463.87%、865.69%、220.19%，振幅较大的相关个股有Azitra Inc、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Viracta Therapeutics, Inc.，振幅分别为64.17%、49.87%、44.22%。Vor Biopharma Inc.公司简介：Vor Biopharma Inc 是一家处于临床阶段的细胞治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204231553a23931d6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204231553a23931d6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","VOR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508314152","title":"Vor Biopharma Inc.盘中异动 股价大跌6.34%报1.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508314152","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508314152?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:47","pubTimestamp":1738594061,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时47分，Vor Biopharma Inc.股票出现异动，股价快速跳水6.34%。截至发稿，该股报1.33美元/股，成交量8.2485万股，换手率0.07%，振幅2.59%。Vor Biopharma Inc.股票所在的生物技术行业中，整体跌幅为0.44%。Vor Biopharma Inc.公司简介：Vor Biopharma Inc 是一家处于临床阶段的细胞治疗公司。公司的产品包括 VOR33。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203224742987971ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203224742987971ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","VOR"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.vorbio.com","stockEarnings":[{"period":"1week","weight":-0.1676},{"period":"1month","weight":0.0672},{"period":"3month","weight":-0.1676},{"period":"6month","weight":-0.4921},{"period":"1year","weight":-0.0506},{"period":"ytd","weight":0.0558}],"compareEarnings":[{"period":"1week","weight":0.0054},{"period":"1month","weight":0.087},{"period":"3month","weight":0.0359},{"period":"6month","weight":0.0542},{"period":"1year","weight":0.3059},{"period":"ytd","weight":0.047}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Vor Biopharma Inc.于2015年12月30日在特拉华州注册成立。该公司是一家临床阶段的生物制药公司，专注于开发一种治疗自身免疫性疾病的新疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.04043},{"month":2,"riseRate":0.6,"avgChangeRate":0.020325},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.093017},{"month":4,"riseRate":0,"avgChangeRate":-0.187339},{"month":5,"riseRate":0.2,"avgChangeRate":-0.276218},{"month":6,"riseRate":0.4,"avgChangeRate":1.31333},{"month":7,"riseRate":0.2,"avgChangeRate":-0.043439},{"month":8,"riseRate":0.4,"avgChangeRate":0.001368},{"month":9,"riseRate":0.4,"avgChangeRate":-0.0543},{"month":10,"riseRate":0.6,"avgChangeRate":-0.046096},{"month":11,"riseRate":0.2,"avgChangeRate":-0.192554},{"month":12,"riseRate":1,"avgChangeRate":0.3146}],"exchange":"NASDAQ","name":"Vor Biopharma Inc.","nameEN":"Vor Biopharma Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Vor Biopharma Inc.(VOR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Vor Biopharma Inc.(VOR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Vor Biopharma Inc.,VOR,Vor Biopharma Inc.股票,Vor Biopharma Inc.股票老虎,Vor Biopharma Inc.股票老虎国际,Vor Biopharma Inc.行情,Vor Biopharma Inc.股票行情,Vor Biopharma Inc.股价,Vor Biopharma Inc.股市,Vor Biopharma Inc.股票价格,Vor Biopharma Inc.股票交易,Vor Biopharma Inc.股票购买,Vor Biopharma Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Vor Biopharma Inc.(VOR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Vor Biopharma Inc.(VOR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}